CSPC Mingfule Pharmaceutical (Guangzhou) Co., Ltd.
3 clinical trials · Sponsor
◉ Watch CSPC Mingfule Pharmaceutical (Guangzhou) Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| Observational Study to Assess the Safety of rhTNK-tPA (Mingfule®) vs. Rt-PA (Actilyse®) in Treating Acute Ischemic Stroke (NCT07519889) | CSPC Mingfule Pharmaceutical (Guangzhou) Co., Ltd. | 2026-04-10 |
| Phase III Clinical Trial of rhTNK-tPA in Treating Acute Ischemic Stroke With Extended Time Window. (NCT07201688) | CSPC Mingfule Pharmaceutical (Guangzhou) Co., Ltd. | 2025-11-30 |
| The Efficacy and Safety of rhTNK-tPA in Comparison With Alteplase(Rt-PA) as Fibrinolytic Therapy of Acute STEMI (NCT02835534) | CSPC Mingfule Pharmaceutical (Guangzhou) Co., Ltd. | 2016-05-01 |
Track CSPC Mingfule Pharmaceutical (Guangzhou) Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.